07.07.2020

EU in 'constructive' talks with Gilead to nab remdesivir amid U.S. supply grab: report

EU in 'constructive' talks with Gilead to nab remdesivir amid U.S. supply grab: report aliu Tue, 07/07/2020 - 10:35
07.07.2020

Novavax inks $1.6B Warp Speed deal to fund COVID vaccine's phase 3 testing, manufacturing

Novavax inks $1.6B Warp Speed deal to fund COVID vaccine's phase 3 testing, manufacturing esagonowsky Tue, 07/07/2020 - 09:20
07.07.2020

Bayer hits Roundup settlement snag as judge 'tentatively inclined' to reject $1.25B deal

Bayer hits Roundup settlement snag as judge 'tentatively inclined' to reject $1.25B deal aliu Tue, 07/07/2020 - 08:52
07.07.2020

Regeneron bags $450M deal with U.S. government for coronavirus antibody cocktail supply

Regeneron bags $450M deal with U.S. government for coronavirus antibody cocktail supply kblankenship Tue, 07/07/2020 - 07:47
07.06.2020

J&J expands COVID-19 vaccine pact with Catalent for finishing work at Italian facility

J&J expands COVID-19 vaccine pact with Catalent for finishing work at Italian facility kblankenship Mon, 07/06/2020 - 19:28
07.06.2020

CureVac scores $85M loan to scale COVID-19 shot manufacturing at German site

CureVac scores $85M loan to scale COVID-19 shot manufacturing at German site kblankenship Mon, 07/06/2020 - 19:03
07.06.2020

Eli Lilly launches low blood sugar awareness campaign with 'American Idol' alum

Eli Lilly launches low blood sugar awareness campaign with 'American Idol' alum beth.bulik Mon, 07/06/2020 - 17:07
07.06.2020

J&J sews up 5 years of coronavirus vaccine supply in $480M-plus deal with Emergent

J&J sews up 5 years of coronavirus vaccine supply in $480M-plus deal with Emergent kblankenship Mon, 07/06/2020 - 10:12
07.06.2020

GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options

GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options aliu Mon, 07/06/2020 - 10:07
07.06.2020

Sanofi, Regeneron shut down Kevzara trial in COVID-19 after finding no benefit for ventilated patients

Sanofi, Regeneron shut down Kevzara trial in COVID-19 after finding no benefit for ventilated patients kblankenship Mon, 07/06/2020 - 09:20